Navigation Links
Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
Date:4/6/2011

SAN DIEGO, April 6, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) and Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the signing of an exclusive two-year co-promotion agreement to market DIFICID™ (fidaxomicin), in the United States.  DIFICID is a novel antibiotic currently being reviewed for market approval by the FDA for the treatment of Clostridium difficile infection (CDI), which is also known as Clostridium difficile-associated diarrhea (CDAD).  On April 5, 2011, the FDA's Anti-Infective Drugs Advisory Committee voted unanimously that the clinical evidence submitted by Optimer demonstrated the safety and effectiveness of DIFICID for the treatment of CDI, thereby recommending approval of DIFICID as a treatment for CDI. The FDA is expected to complete its review of DIFICID and deliver a decision on market approval by a Prescription Drug User Fee Act (PDUFA) goal date of May 30, 2011.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

Under the terms of the agreement, Optimer and Cubist will co-promote DIFICID to physicians, hospitals, long-term care facilities and other healthcare institutions in the United States. Optimer and Cubist will also jointly provide medical affairs support for the product. Optimer plans to strategically build its sales force and medical affairs team.  Optimer's team will be complemented by Cubist's existing U.S. hospital sales force and medical affairs team which is already dedicated to the antibiotic space for CUBICIN® (daptomycin for injection), Cubist's therapy for Staphylococcus aureus bacteremia, including right-sided endocarditis, and complicated skin infections caused by certain Gram-positive b
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
2. Trading Halted Today in Optimer Pharmaceuticals Stock
3. Optimer Pharmaceuticals Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile Infection (CDI) in Hospital Patients
4. Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality
5. Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection
6. Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
7. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results
8. Optimer Pharmaceuticals to Present at March 2011 Investor Conferences
9. Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock
10. Optimer Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
11. Optimer Pharmaceuticals and Astellas Announce Collaboration to Commercialize Fidaxomicin for Clostridium difficile infection (CDI) in Europe and Certain Other Countries in Middle East, Africa and CIS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Research and Markets ... Cancer Therapeutics Market & Pipeline Insight 2014" report ... developed to prevent and eradicate the prevalence of cancer ... are confined to low specificity, safety and large number ... for a better solution. It has been discovered that ...
(Date:8/29/2014)... SPRING, Md. , Aug. 29, 2014  United ... that the U.S. District Court for the District of ... its favor in the company,s case against Sandoz, Inc. ... Judge Peter Sheridan ruled that U.S. Patent ... Inc., and enjoined Sandoz from marketing its generic product ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
(Date:8/30/2014)... Saturday 30 August 2014: The first comprehensive ESC ... presented at ESC Congress 2014 by Task Force Chairpersons ... , The "2014 ESC Guidelines on the diagnosis and ... European Heart Journal (1) and on ... recommendations were published in 2001 but they were restricted ...
(Date:8/30/2014)... Saturday 30 August 2014: A new sudden ... identifies candidates for implantable cardioverter defibrillators (ICDs) in ... ESC Congress by Task Force Chairperson Professor Perry ... Diagnosis and Management of Hypertrophic Cardiomyopathy" are published ... (1) and on the ESC Website. Previous ...
(Date:8/29/2014)... Daily Gossip writes in its review that this is actually ... method promises to teach readers how to eliminate the need ... sources for the production of energy. , Some of ... power. , The Home Made Energy review indicates that ... this is an online guide that will teach its users ...
(Date:8/29/2014)... (PRWEB) August 30, 2014 Indosoft, ... center software, announces the release of its most advanced ... a number of new features as well as updates ... software. , Q-Suite functionality on the presentation side ... TinyMCE into the script builder. This WYSIWYG ...
(Date:8/29/2014)... (PRWEB) August 30, 2014 AGH Healthy ... the Doctors in Delaware at Atlantic General ... free health-related services. In addition to no-cost blood pressure ... offers first aid care at local sports tournaments. ... other medical staff provide free disease management and falls ...
Breaking Medicine News(10 mins):Health News:First comprehensive ESC Guidelines on aortic diseases published 2Health News:First comprehensive ESC Guidelines on aortic diseases published 3Health News:Sudden death predictor identifies ICD candidates in new ESC Guidelines 2Health News:Home Made Energy Review Exposes Simple Method to Access Alternative Energy Sources 2Health News:Indosoft Releases Q-Suite 5.7.7 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 3
... , , WASHINGTON , Jan. ... which shows small businesses continue to struggle under the lagging economy ... decreases in revenue over the past 12 months rose to its ... to get adequate financing for their business. Despite a very dismal ...
... ... charter flight from JFK to Port-au-Prince to bring doctors and relief workers to help ... ... flight organized by the Church of Scientology carried 126 doctors, nurses, emergency medical technicians ...
... , Jan. 19 A shipment of Lutheran World ... Windsor, Md. , today, to be distributed to Haitian earthquake survivors. ... of 650 health kits and 1500 layettes, the first of multiple ... valued at nearly $500,000 and plans to send more ...
... , , PELLA, Iowa , Jan. 19 ... help those in the design, building and remodeling industries build their business ... will spring into action Feb. 2 through May 13 as ... cities. During the free events, attendees can obtain continuing education credits, learn ...
... Kris Freeman hopes for first U.S. cross-country medal since 1976; health ... Kris Freeman is back in the hunt for an ... ski team following a disappointing finish at the 2006 Games in Torino, ... at the 2010 Games in February, suffers from type 1 diabetes, a form ...
... at the University of California, San Diego School of Medicine ... which gliomas, a deadly type of brain tumor, can evade ... growth factor receptor (EGFR),that is crucial for tumor growth. In ... mutation is important not only to initiate the tumor, but ...
Cached Medicine News:Health News:NSBA 2009 Year-End Economic Report: Small Businesses Still Struggling 2Health News:NSBA 2009 Year-End Economic Report: Small Businesses Still Struggling 3Health News:Scientology-Sponsored Charter Flight Brings Medical and Spiritual Aid to Haiti 2Health News:Lutheran World Relief Health Kits, Layettes Enroute to Haiti; More Quilts and Kits Needed 2Health News:Lutheran World Relief Health Kits, Layettes Enroute to Haiti; More Quilts and Kits Needed 3Health News:Register Now for The Pro Expo(TM) Presented by Pella 2Health News:Register Now for The Pro Expo(TM) Presented by Pella 3Health News:In a Cross-Country Comeback, Skier With Type 1 Diabetes Named to U.S. Olympic Team 2Health News:In a Cross-Country Comeback, Skier With Type 1 Diabetes Named to U.S. Olympic Team 3Health News:In a Cross-Country Comeback, Skier With Type 1 Diabetes Named to U.S. Olympic Team 4Health News:Scientists show how brain tumors outsmart drugs 2